Your browser doesn't support javascript.
loading
Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
Farrant, John; Dodd, Susanna; Vaughan, Carly; Reid, Anna; Schmitt, Matthias; Garratt, Clifford; Akhtar, Mohammed; Mahmod, Masliza; Neubauer, Stefan; Cooper, Robert M; Prasad, Sanjay K; Singh, Anvesha; Valkovic, Ladislav; Raman, Betty; Ashkir, Zakariye; Clayton, Dannii; Baroja, Olatz; Duran, Beatriz; Spowart, Catherine; Bedson, Emma; Naish, Josephine H; Harrington, Chris; Miller, Christopher A.
Afiliação
  • Farrant J; BHF Manchester Centre for Heart and Lung Magnetic Resonance Research, Manchester University NHS Foundation Trust, Manchester, UK.
  • Dodd S; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Vaughan C; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.
  • Reid A; Department of Health Data Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
  • Schmitt M; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.
  • Garratt C; BHF Manchester Centre for Heart and Lung Magnetic Resonance Research, Manchester University NHS Foundation Trust, Manchester, UK.
  • Akhtar M; BHF Manchester Centre for Heart and Lung Magnetic Resonance Research, Manchester University NHS Foundation Trust, Manchester, UK.
  • Mahmod M; BHF Manchester Centre for Heart and Lung Magnetic Resonance Research, Manchester University NHS Foundation Trust, Manchester, UK.
  • Neubauer S; Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Cooper RM; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Prasad SK; Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Singh A; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Valkovic L; Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Raman B; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Ashkir Z; Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool, UK.
  • Clayton D; School of Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
  • Baroja O; Cardiology, Royal Brompton and Harefield Hospitals, London, UK.
  • Duran B; Department of Cardiovascular Sciences, University of Leicester and the NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Spowart C; Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Bedson E; Department of Imaging Methods, Institute of Measurement Science, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Naish JH; Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
  • Harrington C; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Miller CA; Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
Heart ; 109(15): 1175-1182, 2023 07 12.
Article em En | MEDLINE | ID: mdl-37137675
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trientina / Cardiomiopatia Hipertrófica Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trientina / Cardiomiopatia Hipertrófica Idioma: En Ano de publicação: 2023 Tipo de documento: Article